Bibliography
- KONSTANTINOPOULOS PA, LEHMANN DF: The cardiovascular toxicity of selective and non selective cyclooxygenase inhibitors: comparisons, contrasts, and aspirin confounding. J. Clin. Pharmacol. (2005) 45:742–750.
- ANTMAN EM, DEMETS D, LOSCALZO J: Cyclooxygenase inhibition and the cardiovascular risk. Circulation (2005) 112:759–770.
- JUNI P, REICHENBACH S, EGGER M: COX 2 inhibitors, traditional NSAIDs and the heart. BM J(2005) 330(7504): 1342–1343.
- FURBERG CD, PSATY BM, FITZGERALD Gk Parecoxib, valdecoxib, and cardiovascular risk. Circulation (2005) 111:249.
- MITCHELL IA et al.: Discontinuation ofVioxx. Lancet (2005) 365(9453):27–28.